Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2865)	6/16/2010 12:18:37 PM
From: Jibacoa	1 Recommendation Read Replies (1) of 3722

QCOR is making another all time H <g> The stock is up 7.89% on volume about 0.45x its ADV bigcharts.marketwatch.com Last week it announced that it has received notification from the FDA that the PDUFA date for the supplemental NDA to approve Acthar for the treatment of infantile spasms has been extended to Sep11. On May 6 the Advisory Committee to the Division of Peripheral and Central Nervous System Drugs of the FDA indicated support for approval of this new Acthar indication. The ACTAY remains at $13.50 As mentioned, if QCOR can get a final approval from the FDA on its Acthar application, it seems that the stock could get to the $15 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next